Literature DB >> 11847210

The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor.

Eva Bengtsson1, Matthias Mörgelin, Takako Sasaki, Rupert Timpl, Dick Heinegård, Anders Aspberg.   

Abstract

PRELP (proline arginine-rich end leucine-rich repeat protein) is a heparin-binding leucine-rich repeat protein in connective tissue extracellular matrix. In search of natural ligands and biological functions of this molecule, we found that PRELP binds the basement membrane heparan sulfate proteoglycan perlecan. Also, recombinant perlecan domains I and V carrying heparan sulfate bound PRELP, whereas other domains without glycosaminoglycan substitution did not. Heparin, but not chondroitin sulfate, inhibited the interactions. Glycosaminoglycan-free recombinant perlecan domain V and mutated domain I did not bind PRELP. The dissociation constants of the PRELP-perlecan interactions were in the range of 3-18 nm as determined by surface plasmon resonance. As expected, truncated PRELP, without the heparin-binding domain, did not bind perlecan. Confocal immunohistochemistry showed that PRELP outlines basement membranes with a location adjacent to perlecan. We also found that PRELP binds collagen type I and type II through its leucine-rich repeat domain. Electron microscopy visualized a complex with PRELP binding simultaneously to the triple helical region of procollagen I and the heparan sulfate chains of perlecan. Based on the location of PRELP and its interaction with perlecan heparan sulfate chains and collagen, we propose a function of PRELP as a molecule anchoring basement membranes to the underlying connective tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847210     DOI: 10.1074/jbc.M108285200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study.

Authors:  James Melrose; Susan Smith; Martin Cake; Richard Read; John Whitelock
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

2.  The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation.

Authors:  Viveka Tillgren; Matthias Mörgelin; Patrik Önnerfjord; Sebastian Kalamajski; Anders Aspberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

4.  The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors.

Authors:  Viveka Tillgren; Patrik Onnerfjord; Lisbet Haglund; Dick Heinegård
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

Review 5.  Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.

Authors:  Dick Heinegård
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

6.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 7.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

8.  Comparative Analysis of the Extracellular Matrix Proteome across the Myotendinous Junction.

Authors:  Kathryn R Jacobson; Sarah Lipp; Andrea Acuna; Yue Leng; Ye Bu; Sarah Calve
Journal:  J Proteome Res       Date:  2020-09-14       Impact factor: 4.466

Review 9.  Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies.

Authors:  James Melrose; Susan M Smith; Christopher B Little; Robert J Moore; Barrie Vernon-Roberts; Robert D Fraser
Journal:  Eur Spine J       Date:  2008-06-27       Impact factor: 3.134

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.